Sachin Shah

903 total citations
25 papers, 737 citations indexed

About

Sachin Shah is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sachin Shah has authored 25 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Sachin Shah's work include Colorectal Cancer Treatments and Studies (4 papers), Platelet Disorders and Treatments (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Sachin Shah is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Platelet Disorders and Treatments (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Sachin Shah collaborates with scholars based in United States, Canada and India. Sachin Shah's co-authors include Jonathan E. Dowell, Gary W. Jean, Anant Sharma, Thu M. Tran, Ronald G. Hall, Charles F. Seifert, Jaime Maerten‐Rivera, Eric McArthur, Greg Knoll and Arsh K. Jain and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Sachin Shah

25 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sachin Shah United States 13 286 211 172 103 80 25 737
Patrick J. Medina United States 14 210 0.7× 163 0.8× 162 0.9× 113 1.1× 61 0.8× 22 719
James E. Ward United States 12 360 1.3× 340 1.6× 100 0.6× 269 2.6× 53 0.7× 16 730
Jill Kolesar United States 19 329 1.2× 296 1.4× 139 0.8× 55 0.5× 61 0.8× 68 948
Hoon‐Gu Kim South Korea 18 321 1.1× 112 0.5× 192 1.1× 51 0.5× 84 1.1× 42 713
Sophie Broutin France 16 311 1.1× 213 1.0× 96 0.6× 99 1.0× 30 0.4× 48 787
J. Alexandre France 15 370 1.3× 170 0.8× 205 1.2× 55 0.5× 27 0.3× 45 755
E. Boven Netherlands 11 503 1.8× 308 1.5× 116 0.7× 40 0.4× 58 0.7× 25 770
Johanna N.H. Timmer-Bonte Netherlands 15 523 1.8× 242 1.1× 212 1.2× 54 0.5× 22 0.3× 38 910
Audrey Bellesœur France 12 283 1.0× 174 0.8× 196 1.1× 55 0.5× 15 0.2× 38 662
Haa‐Na Song South Korea 16 361 1.3× 156 0.7× 282 1.6× 21 0.2× 87 1.1× 47 815

Countries citing papers authored by Sachin Shah

Since Specialization
Citations

This map shows the geographic impact of Sachin Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachin Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachin Shah more than expected).

Fields of papers citing papers by Sachin Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachin Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachin Shah. The network helps show where Sachin Shah may publish in the future.

Co-authorship network of co-authors of Sachin Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Sachin Shah. A scholar is included among the top collaborators of Sachin Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachin Shah. Sachin Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Megan, et al.. (2020). Post-CaRMS match survey for fourth year medical students. SHILAP Revista de lepidopterología. 11(3). e101–e110. 4 indexed citations
2.
Shah, Sachin, et al.. (2019). A model to predict NAPLEX outcomes and identify students needing additional preparation. Currents in Pharmacy Teaching and Learning. 11(8). 810–817. 9 indexed citations
3.
Rudolph, Michael, Jaime Maerten‐Rivera, Brenda S. Bray, et al.. (2019). A Study of the Relationship Between the PCOA and NAPLEX Using a Multi-institutional Sample. American Journal of Pharmaceutical Education. 83(2). 6867–6867. 15 indexed citations
4.
Chokshi, Saurin, et al.. (2014). Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients.. PubMed. 34(10). 5543–6. 1 indexed citations
5.
Shah, Sachin, Eric McArthur, Jamie L Fleet, et al.. (2014). Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study. PLoS ONE. 9(10). e110165–e110165. 21 indexed citations
6.
Hall, Ronald G., et al.. (2013). Dosing Considerations for Obese Patients Receiving Cancer Chemotherapeutic Agents. Annals of Pharmacotherapy. 47(12). 1666–1674. 22 indexed citations
7.
Sharma, Anant, et al.. (2012). Vemurafenib. Drugs. 72(17). 2207–2222. 80 indexed citations
8.
Hall, Ronald G., et al.. (2011). Evaluation of Chemotherapy-Induced Severe Myelosuppression Incidence in Obese Patients With Capped Dosing. Journal of Oncology Practice. 7(1). 13–17. 24 indexed citations
9.
Shah, Sachin, et al.. (2011). Pazopanib. Drugs. 71(4). 1–1. 109 indexed citations
10.
Shah, Sachin, et al.. (2010). Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid. Supportive Care in Cancer. 20(1). 87–93. 10 indexed citations
11.
Shah, Sachin, et al.. (2010). Comparison of the 5‐Fluorouracil‐Warfarin and Capecitabine‐Warfarin Drug Interactions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(12). 1259–1265. 7 indexed citations
12.
Shah, Sachin. (2008). A newer immunoglobulin intravenous (IGIV) – Gammagard®liquid 10%: Evaluation of efficacy, safety, tolerability and impact on patient care. Expert Opinion on Biological Therapy. 8(6). 799–804. 11 indexed citations
13.
Jean, Gary W. & Sachin Shah. (2008). Epidermal Growth Factor Receptor Monoclonal Antibodies for the Treatment of Metastatic Colorectal Cancer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(6). 742–754. 74 indexed citations
14.
Craig, Michael, Sandip Shah, Martin S. Tallman, et al.. (2008). A Phase II Trial of Darinaparsin in Advanced Lymphomas: Report on Safety and Activity.. Blood. 112(11). 1562–1562. 2 indexed citations
15.
Shah, Sachin & Thu M. Tran. (2007). Lenalidomide in Myelodysplastic Syndrome and Multiple Myeloma. Drugs. 67(13). 1869–1881. 30 indexed citations
16.
Shah, Sachin, et al.. (2007). Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) splice variants from bovine cardiac muscle. Gene. 396(2). 283–292. 2 indexed citations
17.
Shah, Sachin, et al.. (2006). Pemetrexed, a Novel Antifolate Therapeutic Alternative for Cancer Chemotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(5). 641–654. 29 indexed citations
18.
Shah, Sachin, et al.. (2006). Evaluation of Clinical Pharmacy Services in a Hematology/Oncology Outpatient Setting. Annals of Pharmacotherapy. 40(9). 1527–1533. 75 indexed citations
19.
Shah, Sachin. (2005). Pharmacy considerations for the use of IGIV therapy. American Journal of Health-System Pharmacy. 62(16_Supplement_3). S5–S11. 30 indexed citations
20.
Shah, Sachin, et al.. (2003). Gefitinib (ZD1839, Iressa®): a selective epidermal growth factor receptor-tyrosine kinase inhibitor. Journal of Oncology Pharmacy Practice. 9(4). 151–160. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026